Veeva Commercial Summit is one of the largest industry events in North America for commercial and medical affairs leaders.

Privately-held Alchemab Therapeutics, a biotech that uses the power of human immune evolution to identify and develop ...

Recursion Pharmaceuticals has narrowed its drug development pipeline as it seeks to reduce costs and reprioritise resources.

Q1 2025 Earnings Conference Call May 6, 2025 2:00 PM ETCompany ParticipantsScott Lauber - President and CEOXia Liu ...

Halozyme Therapeutics, Inc. ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, will present and host investor meetings at the BofA Securities 2025 Healthcare ...

Bristol Myers Squibb helmsman Chris Boerner joined a growing list of life sciences leaders announcing major U.S. investments in the face of potential pharmaceutical import tariffs. | Bristol Myers ...

Lilly licenses Alchemab’s ALS antibody ATLX-1282 in $415mn deal, expanding its neuroscience pipeline with a novel, ...

Baron Fifth Avenue Growth Fund declined during the first quarter of 2025, underperforming its benchmark, the Russell 1000 ...

Palantir (PLTR) reported strong first-quarter results after the close on Monday, showcasing rapid growth across its U.S.

Concerns are mounting about the dollar's safe haven appeal, according to a majority of FX strategists surveyed by Reuters who ...

Astraveus SAS ("Astraveus" or the "Company"), the benchtop cell factory company, today announces that it has entered into a strategic partnership with The Netherlands Center for the Clinical ...

While major market indexes like the S&P 500 have struggled to gain traction in 2025 and remain in the red YTD, certain ...